{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:43:50Z","timestamp":1768268630352,"version":"3.49.0"},"reference-count":17,"publisher":"Jaypee Brothers Medical Publishing","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.4103\/ijccm.ijccm_243_17","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T12:23:20Z","timestamp":1514895800000},"page":"825-829","source":"Crossref","is-referenced-by-count":4,"title":["Monotherapy versus combination therapy against nonbacteremic carbapenem-resistant gram-negative infections: a retrospective observational study"],"prefix":"10.5005","volume":"21","author":[{"given":"Abdul","family":"Ghafur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Raja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Raja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. G.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balaji","family":"Venkatachalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","published-online":{"date-parts":[[2017]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"1. Kim YJ, Kim SI, Hong KW, Kim YR, Park YJ, Kang MW, et al. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: Impact of appropriate antimicrobial therapy. J Korean Med Sci 2012;27:471-5.","DOI":"10.3346\/jkms.2012.27.5.471"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"2. Andria N, Henig O, Kotler O, Domchenko A, Oren I, Zuckerman T, et al. Mortality burden related to infection with carbapenem-resistant gram-negative bacteria among haematological cancer patients: A retrospective cohort study. J Antimicrob Chemother 2015;70:3146-53.","DOI":"10.1093\/jac\/dkv218"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"3. Ghafur A, Mathai D, Muruganathan A, Jayalal JA, Kant R, Chaudhary D, et al. The Chennai declaration: A roadmap to tackle the challenge of antimicrobial resistance. Indian J Cancer 2013;50:71-3.","DOI":"10.4103\/0019-509X.104065"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"4. Falagas ME, Lourida P, Poulikakos P, Rafailidis PI, Tansarli GS. Antibiotic treatment of infections due to carbapenem-resistant enterobacteriaceae: Systematic evaluation of the available evidence. Antimicrob Agents Chemother 2014;58:654-63.","DOI":"10.1128\/AAC.01222-13"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"5. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: Importance of combination therapy. Clin Infect Dis 2012;55:943-50.","DOI":"10.1093\/cid\/cis588"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"6. Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: Superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012;56:2108-13.","DOI":"10.1128\/AAC.06268-11"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"7. Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: Lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 2014;58:2322-8.","DOI":"10.1128\/AAC.02166-13"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"8. Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, et al. Colistin therapy for microbiologically documented multidrug-resistant gram-negative bacterial infections: A retrospective cohort study of 258 patients. Int J Antimicrob Agents 2010;35:194-9.","DOI":"10.1016\/j.ijantimicag.2009.10.005"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"9. Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 2011;17:1798-803.","DOI":"10.1111\/j.1469-0691.2011.03514.x"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"10. Lee GC, Burgess DS. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: A review of published case series and case reports. Ann Clin Microbiol Antimicrob 2012;11:32.","DOI":"10.1186\/1476-0711-11-32"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"11. Paul M, Carmeli Y, Durante-Mangoni E, Mouton JW, Tacconelli E, Theuretzbacher U, et al. Combination therapy for carbapenem-resistant gram-negative bacteria. J Antimicrob Chemother 2014;69:2305-9.","DOI":"10.1093\/jac\/dku168"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"12. Ghafur AK, Vidyalakshmi PR, Kannaian P, Balasubramaniam R. Clinical study of carbapenem sensitive and resistant gram-negative bacteremia in neutropenic and nonneutropenic patients: The first series from India. Indian J Cancer 2014;51:453-5.","DOI":"10.4103\/0019-509X.175362"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"13. Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, et al. Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 2015;70:2133-43.","DOI":"10.1093\/jac\/dkv200"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"14. Guti\u00e9rrez-Guti\u00e9rrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Pa\u00f1o-Pardo JR, et al. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing enterobacteriaceae (INCREMENT): A retrospective cohort study. Lancet Infect Dis 2017;17:726-34.","DOI":"10.1016\/S1473-3099(17)30521-2"},{"key":"ref=15","unstructured":"15. Shah PG, Shah SR. Treatment and outcome of carbapenem-resistant gram-negative bacilli blood-stream infections in a tertiary care hospital. J Assoc Physicians India 2015;63:14-8."},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"16. Porwal R, Gopalakrishnan R, Rajesh NJ, Ramasubramanian V. Carbapenem resistant gram-negative bacteremia in an Indian Intensive Care Unit: A review of the clinical profile and treatment outcome of 50 patients. Indian J Crit Care Med 2014;18:750-3.","DOI":"10.4103\/0972-5229.144021"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"17. Kazi M, Shetty A, Rodrigues C. The carbapenemase menace: Do dual mechanisms code for more resistance? Infect Control Hosp Epidemiol 2015;36:116-7.","DOI":"10.1017\/ice.2014.33"}],"container-title":["Indian Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijccm.org\/doi\/pdf\/10.4103\/ijccm.IJCCM_243_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T12:12:52Z","timestamp":1622117572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijccm.org\/doi\/10.4103\/ijccm.IJCCM_243_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017]]}},"alternative-id":["10.4103\/ijccm.IJCCM_243_17"],"URL":"https:\/\/doi.org\/10.4103\/ijccm.ijccm_243_17","relation":{},"ISSN":["0972-5229","1998-359X"],"issn-type":[{"value":"0972-5229","type":"print"},{"value":"1998-359X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}